214 related articles for article (PubMed ID: 27419372)
1. CD109 is identified as a potential nasopharyngeal carcinoma biomarker using aptamer selected by cell-SELEX.
Jia W; Ren C; Wang L; Zhu B; Jia W; Gao M; Zeng F; Zeng L; Xia X; Zhang X; Fu T; Li S; Du C; Jiang X; Chen Y; Tan W; Zhao Z; Liu W
Oncotarget; 2016 Aug; 7(34):55328-55342. PubMed ID: 27419372
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation-sensitive high resolution melting.
Yang X; Dai W; Kwong DL; Szeto CY; Wong EH; Ng WT; Lee AW; Ngan RK; Yau CC; Tung SY; Lung ML
Int J Cancer; 2015 Feb; 136(4):E127-35. PubMed ID: 25196065
[TBL] [Abstract][Full Text] [Related]
3. CD109 is a novel marker for squamous cell/adenosquamous carcinomas of the gallbladder.
Dong F; Lu C; Chen X; Guo Y; Liu J
Diagn Pathol; 2015 Aug; 10():137. PubMed ID: 26249215
[TBL] [Abstract][Full Text] [Related]
4. The effects of doxorubicin loaded aptamer S3-linked DNA tetrahedrons on nasopharyngeal carcinoma.
Liu X; Jiang B; Cheng A; Guo Y; Wang L; Liu W; Yin W; Li Y; Jiang X; Ren C
J Otolaryngol Head Neck Surg; 2023 Dec; 52(1):79. PubMed ID: 38087297
[TBL] [Abstract][Full Text] [Related]
5. A novel molecular marker of breast cancer stem cells identified by cell-SELEX method.
Lu M; Zhou L; Zheng X; Quan Y; Wang X; Zhou X; Ren J
Cancer Biomark; 2015; 15(2):163-70. PubMed ID: 25519016
[TBL] [Abstract][Full Text] [Related]
6. Screening and Identifying a Novel ssDNA Aptamer against Alpha-fetoprotein Using CE-SELEX.
Dong L; Tan Q; Ye W; Liu D; Chen H; Hu H; Wen D; Liu Y; Cao Y; Kang J; Fan J; Guo W; Wu W
Sci Rep; 2015 Oct; 5():15552. PubMed ID: 26497223
[TBL] [Abstract][Full Text] [Related]
7. CD109, a negative regulator of TGF-β signaling, is a putative risk marker in diffuse large B-cell lymphoma.
Yokoyama M; Ichinoe M; Okina S; Sakurai Y; Nakada N; Yanagisawa N; Jiang SX; Numata Y; Umezawa A; Miyazaki K; Higashihara M; Murakumo Y
Int J Hematol; 2017 May; 105(5):614-622. PubMed ID: 28032275
[TBL] [Abstract][Full Text] [Related]
8. Single-walled carbon nanotubes (SWCNTs)-assisted cell-systematic evolution of ligands by exponential enrichment (cell-SELEX) for improving screening efficiency.
Tan Y; Guo Q; Xie Q; Wang K; Yuan B; Zhou Y; Liu J; Huang J; He X; Yang X; He C; Zhao X
Anal Chem; 2014 Oct; 86(19):9466-72. PubMed ID: 25184732
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of prostate stem cell antigen (PSCA) by Slug promotes metastasis in nasopharyngeal carcinoma.
Wang L; Sang Y; Tang J; Zhang RH; Luo D; Chen M; Deng WG; Kang T
J Pathol; 2015 Dec; 237(4):411-22. PubMed ID: 26147638
[TBL] [Abstract][Full Text] [Related]
10. Cancer protein biomarker discovery based on nucleic acid aptamers.
Xiong H; Yan J; Cai S; He Q; Peng D; Liu Z; Liu Y
Int J Biol Macromol; 2019 Jul; 132():190-202. PubMed ID: 30926499
[TBL] [Abstract][Full Text] [Related]
11. RPA3 is a potential marker of prognosis and radioresistance for nasopharyngeal carcinoma.
Qu C; Zhao Y; Feng G; Chen C; Tao Y; Zhou S; Liu S; Chang H; Zeng M; Xia Y
J Cell Mol Med; 2017 Nov; 21(11):2872-2883. PubMed ID: 28557284
[TBL] [Abstract][Full Text] [Related]
12. Biomarker discovery of nasopharyngeal carcinoma by proteomics.
Xiao L; Xiao T; Wang ZM; Cho WC; Xiao ZQ
Expert Rev Proteomics; 2014 Apr; 11(2):215-25. PubMed ID: 24611579
[TBL] [Abstract][Full Text] [Related]
13. Selection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell capture.
Song Y; Zhu Z; An Y; Zhang W; Zhang H; Liu D; Yu C; Duan W; Yang CJ
Anal Chem; 2013 Apr; 85(8):4141-9. PubMed ID: 23480100
[TBL] [Abstract][Full Text] [Related]
14. Aberrant CpG island methylation of PTEN is an early event in nasopharyngeal carcinoma and a potential diagnostic biomarker.
Li J; Gong P; Lyu X; Yao K; Li X; Peng H
Oncol Rep; 2014 May; 31(5):2206-12. PubMed ID: 24604064
[TBL] [Abstract][Full Text] [Related]
15. Far upstream element-binding protein 1 is a prognostic biomarker and promotes nasopharyngeal carcinoma progression.
Liu ZH; Hu JL; Liang JZ; Zhou AJ; Li MZ; Yan SM; Zhang X; Gao S; Chen L; Zhong Q; Zeng MS
Cell Death Dis; 2015 Oct; 6(10):e1920. PubMed ID: 26469968
[TBL] [Abstract][Full Text] [Related]
16. An improved SELEX technique for selection of DNA aptamers binding to M-type 11 of Streptococcus pyogenes.
Hamula CL; Peng H; Wang Z; Tyrrell GJ; Li XF; Le XC
Methods; 2016 Mar; 97():51-7. PubMed ID: 26678795
[TBL] [Abstract][Full Text] [Related]
17. Rta-IgG as a biomarker for diagnosis and post treatment prognostic of nasopharyngeal carcinoma.
Xu XF; Lu RQ; Xiao R; Zhou L; Zhao XM; Hu XC; Gao X; Guo L
Cancer Biomark; 2016; 16(3):467-76. PubMed ID: 27062704
[TBL] [Abstract][Full Text] [Related]
18. Screening and identification of the nucleic acid aptamers in nasopharyngeal carcinoma.
Chen WX; Zhang KH; Zou XS; Chen YQ; Li JG
Genet Mol Res; 2013 Dec; 12(4):6850-7. PubMed ID: 24391032
[TBL] [Abstract][Full Text] [Related]
19. Joint quantitative measurement of hTERT mRNA in both peripheral blood and circulating tumor cells of patients with nasopharyngeal carcinoma and its clinical significance.
Fu X; Shen C; Wang H; Chen F; Li G; Wen Z
BMC Cancer; 2017 Jul; 17(1):479. PubMed ID: 28693532
[TBL] [Abstract][Full Text] [Related]
20. Evolution of DNA aptamers against esophageal squamous cell carcinoma using cell-SELEX.
Chen X; Zhang Y; Shi Y; Niu T; Li B; Guo L; Qiao Y; Zhao J; Yuan B; Liu K
Analyst; 2021 Jun; 146(13):4180-4187. PubMed ID: 34105524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
